|
Canada-0-Musicians Azienda Directories
|
Azienda News:
- OpenEvidence
An Official AI Partner of The New England Journal of Medicine OpenEvidence content includes figures, tables, multimedia and full-text clinical findings from The New England Journal of Medicine
- About | OpenEvidence
An Official AI Partner of The New England Journal of Medicine OpenEvidence content includes figures, tables, multimedia and full-text clinical findings from The New England Journal of Medicine
- OpenEvidence Launches “Visits” : Real-Time Medical Intelligence for the . . .
Visits can serve as your personal digital Clinical Assistant, integrating real-time medical intelligence directly into your notes Throughout each visit, OpenEvidence enriches your assessment and plan by automatically surfacing the latest clinical evidence and guidelines directly within your documentation workflow
- OpenEvidence AI becomes the first AI in history to score above 90% on . . .
OpenEvidence AI, the large language model-based artificial intelligence powering the automatic ingestion, analysis, synthesis, and research on openevidence com, has reached a new milestone as the first AI to score over 90% on the United States Medical Licensing Examination (USMLE)
- Announcements - OpenEvidence
Sutter Health Collaborates with OpenEvidence to Bring Evidence-Based, AI-Powered Insights into Physician Workflows February 11, 2026
- OpenEvidence Creates the First AI in History to Score a Perfect 100% on . . .
OpenEvidence, a medical search platform that currently provides evidence-based clinical decision and practice support for over 40% of physicians in the United States, was the first to develop an AI system to score over 90% on the USMLE
- OpenEvidence, the Fastest-Growing Application for Physicians in History . . .
CAMBRIDGE, MA, July 15, 2025 – OpenEvidence, the most widely used medical search and AI application among verified U S clinicians, today announced a $210 million Series B round at a $3 5 Billion valuation
- OpenEvidence to Become a Mayo Clinic Platform Accelerate Company
OpenEvidence, an AI company pursuing foundational work in aligning Large Language Models (LLMs) to the medical domain, announced today it is to become a Mayo Clinic Platform Accelerate company As part of Mayo Clinic Platform Accelerate, OpenEvidence will collaborate with Mayo Clinic Platform to improve how health care information is structured and discovered
- NCCN and OpenEvidence Collaborate to Bring Clinical Oncology Guidelines . . .
PLYMOUTH MEETING, PA, and MIAMI, FL — Nov 5, 2025 — The National Comprehensive Cancer Network® (NCCN®) and OpenEvidence, the leading AI-powered medical search and decision-support platform, today announced a licensing agreement to make NCCN’s trusted, evidence-based oncology guidelines accessible through OpenEvidence’s medical artificial intelligence technology Through this
- OpenEvidence Collaborates with Microsoft to Expand AI Leadership in . . .
Miami, FL and Boston, MA — October 19th, 2025 — OpenEvidence, the leader in AI-powered medical search and evidence synthesis, today announced a collaboration with Microsoft to integrate OpenEvidence’s technology across Microsoft clinical applications starting with the Dragon Copilot ambient platform The collaboration positions OpenEvidence and Microsoft at the forefront of delivering
|
|